Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.17
+0.8%
$0.19
$0.16
$1.09
$5.02M0.191.92 million shs107,543 shs
Isoray, Inc. stock logo
ISR
Isoray
$0.37
$0.19
$0.45
$54.57M1.48290,697 shs145,000 shs
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$6.86
+0.1%
$8.84
$3.78
$13.62
$378.81M1.67182,515 shs124,448 shs
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$1.27
+0.5%
$1.24
$0.75
$7.44
$7.86M-1.119,350 shs646 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-1.41%-1.93%-9.41%-1.41%-78.76%
Isoray, Inc. stock logo
ISR
Isoray
0.00%0.00%0.00%0.00%0.00%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-4.73%-12.40%-23.55%-30.67%+15.71%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
0.00%-7.35%-4.73%+32.63%-69.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Isoray, Inc. stock logo
ISR
Isoray
N/AN/AN/AN/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/A
Isoray, Inc. stock logo
ISR
Isoray
N/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.70N/AN/A($0.03) per share-5.63
Isoray, Inc. stock logo
ISR
Isoray
$10.80M0.00N/AN/A$0.43 per share0.00
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$700K541.16N/AN/A$0.81 per share8.47
Vapotherm, Inc. stock logo
VAPO
Vapotherm
$68.67M0.11N/AN/A($9.01) per share-0.14

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$1.24N/AN/A-166.79%-35.31%-13.43%5/9/2024 (Estimated)
Isoray, Inc. stock logo
ISR
Isoray
-$7.27M-$0.07N/AN/AN/A-115.91%-17.12%-16.15%N/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-$42.21M-$0.89N/AN/AN/A-112.74%-61.09%5/9/2024 (Estimated)
Vapotherm, Inc. stock logo
VAPO
Vapotherm
-$58.19M-$9.90N/AN/A-84.74%N/A-65.84%5/1/2024 (Estimated)

Latest ISR, PLSE, VAPO, and AFIB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A-$0.21-$0.21-$0.20N/AN/A
2/22/2024Q4 2023
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/A-$1.60-$1.60-$1.60N/A$19.73 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
Isoray, Inc. stock logo
ISR
Isoray
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
1.10
2.44
2.22
Isoray, Inc. stock logo
ISR
Isoray
N/A
14.38
13.99
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A
6.76
6.76
Vapotherm, Inc. stock logo
VAPO
Vapotherm
N/A
2.43
1.23

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
Isoray, Inc. stock logo
ISR
Isoray
11.32%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
76.95%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
43.08%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
3.50%
Isoray, Inc. stock logo
ISR
Isoray
2.42%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
69.70%
Vapotherm, Inc. stock logo
VAPO
Vapotherm
15.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
23029.72 million28.68 millionOptionable
Isoray, Inc. stock logo
ISR
Isoray
N/A142.11 million138.67 millionNot Optionable
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
6155.22 million16.73 millionOptionable
Vapotherm, Inc. stock logo
VAPO
Vapotherm
1826.21 million5.23 millionOptionable

ISR, PLSE, VAPO, and AFIB Headlines

SourceHeadline
Head to Head Comparison: Delcath Systems (NASDAQ:DCTH) vs. Vapotherm (NYSE:VAPO)Head to Head Comparison: Delcath Systems (NASDAQ:DCTH) vs. Vapotherm (NYSE:VAPO)
americanbankingnews.com - April 21 at 1:26 AM
Onymos Powers Connected Cloud App for Global Medical Technology Company, VapothermOnymos Powers Connected Cloud App for Global Medical Technology Company, Vapotherm
dbta.com - March 25 at 5:37 PM
Vapotherm to debut home ventilator to improve patient careVapotherm to debut home ventilator to improve patient care
msn.com - March 20 at 7:36 PM
Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)Onymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
finance.yahoo.com - March 20 at 7:36 PM
Vapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADEVapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
finance.yahoo.com - March 15 at 10:23 AM
Dr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherms High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfortDr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exacerbations of COPD, while improving patient comfort
prnewswire.com - March 6 at 6:45 AM
Vapotherms HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South Americas Largest Health Care MarketVapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
prnewswire.com - February 29 at 6:45 AM
Vapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsVapotherm, Inc.: Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
finanznachrichten.de - February 23 at 7:30 AM
Vapotherm: Q4 Earnings SnapshotVapotherm: Q4 Earnings Snapshot
chron.com - February 22 at 9:28 PM
Vapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsVapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
prnewswire.com - February 22 at 4:10 PM
Innovations Shaping The Future Of Standalone High Flow Oxygen Therapy Devices Market DynamicsInnovations Shaping The Future Of Standalone High Flow Oxygen Therapy Devices Market Dynamics
opprairie.com - February 12 at 10:06 AM
Vapotherm: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And ExhibitsVapotherm: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And Exhibits
cbonds.com - December 17 at 8:45 AM
OTC Markets Group Welcomes Vapotherm, Inc. to OTCQXOTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
financialpost.com - December 15 at 7:08 AM
NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)NYSE to Commence Delisting Proceedings Against Vapotherm, Inc. (VAPO)
finance.yahoo.com - December 14 at 8:20 PM
Vapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting PlanVapotherm Shares Suspended on NYSE, Company Previously Announced Voluntary Delisting Plan
marketwatch.com - December 14 at 8:20 PM
Vapotherm Shares Decline 22% on Voluntary Delisting Grom NYSEVapotherm Shares Decline 22% on Voluntary Delisting Grom NYSE
marketwatch.com - December 11 at 1:11 PM
Vapotherm slips on announcing voluntary delisting from NYSE to OTCQX MarketplaceVapotherm slips on announcing voluntary delisting from NYSE to OTCQX Marketplace
msn.com - December 11 at 8:11 AM
Vapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQXVapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX
finance.yahoo.com - December 11 at 8:11 AM
Vapotherm Educates over 8,000 Clinicians in Respiratory Care MonthVapotherm Educates over 8,000 Clinicians in Respiratory Care Month
finance.yahoo.com - November 28 at 8:21 PM
Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call TranscriptVapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 2:28 PM
Vapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52MVapotherm GAAP EPS of -$2.38 misses by $0.18, revenue of $15.2M misses by $1.52M
msn.com - November 8 at 7:38 PM
Vapotherm Reports Third Quarter 2023 Financial ResultsVapotherm Reports Third Quarter 2023 Financial Results
finance.yahoo.com - November 8 at 7:38 PM
Vapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo FinanceVapotherm, Inc. (VAPO) stock price, news, quote & history – Yahoo Finance
uk.finance.yahoo.com - November 8 at 9:36 AM
Earnings Outlook For VapothermEarnings Outlook For Vapotherm
benzinga.com - November 7 at 6:13 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Acutus Medical logo

Acutus Medical

NASDAQ:AFIB
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
Isoray logo

Isoray

NYSE:ISR
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.
Pulse Biosciences logo

Pulse Biosciences

NASDAQ:PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Vapotherm logo

Vapotherm

NYSE:VAPO
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.